Article ID Journal Published Year Pages File Type
5824825 Clinical Therapeutics 2015 11 Pages PDF
Abstract
There is currently little evidence to support the use of sildenafil in term or near-term infants with persistent pulmonary hypertension of the newborn in areas in which inhaled nitric oxide is available. More data are needed to determine the effectiveness and dosing of sildenafil in improving outcomes for term and premature infants. Sildenafil dosing and safety studies are needed, especially among premature infants, before efficacy trials are performed.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , ,